Form 4 for NEO NEOGENOMICS INC
Accepted 2026-09-03 17:01:30 ET · period of report 2026-09-01 · accession 0001628280-26-060499 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 17:01 | 2026-09-01 | NEO | Olivo Alicia C | EVP, GC, Business Development | F - Tax | $0.00 | -2,692 | 90.9K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | F | D | 2,692 | $0.00 | 90,875 | D | — | — | (F1) Shares surrendered to NeoGenomics, Inc. for retirement to satisfy tax obligations in connection with the September 1, 2026 vesting of restricted stock. |